688062 迈威生物
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额(668,221)(782,728)(719,171)(422,403)(514,987)
投资活动产生之现金流量净额(203,172)(509,623)(602,803)12,836(357,221)
筹资活动产生之现金流量净额827,134444,9363,715,810198,9421,155,175
汇率变动对现金及现金等价物的影响(934)1,4032,264(1,006)(1,720)
现金及现金等价物净增加/(减少)(45,192)(846,011)2,396,100(211,630)281,246
期初现金及现金等价物余额1,643,6332,489,64593,545305,17523,929
期末现金及现金等价物余额1,598,4411,643,6332,489,64593,545305,175